Log In
Print
BCIQ
Print
Print this Print this
 

KHK4827

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionAnti-Interleukin-17 (IL-17) receptor (IL17R) humanized antibody
Molecular Target Interleukin-17 (IL-17) receptor (IL17R) (IL17RA)
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase III
IndicationPsoriasis
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today